SLC1A2 and amyotrophic lateral sclerosis: Reduced GLT1 protein levels have been observed in patients diagnosed with Huntington’s Disease (HD) or Amyotrophic Lateral Sclerosis (ALS), as well as in several animal models of these NDDs12–16.